Office of Sponsored Programs
News and Updates
NEW 2/13/2023 - Announcement of Energy & Industrial Opportunites
NSF FUNDING OPPORTUNITES WEBSITE:
https://beta.nsf.gov/funding/opportunities
NEW NSF PAPPG 2023:
https://beta.nsf.gov/policies/pappg/23-1
NSF HELP FROM OSP:
The new OSP NSF 2023 Checklist is now ready. Please contact us with any questions. Please let us know of any upcoming proposals, so we can help you achieve the best possible submission.
Weekly NIH Funding Opportunities and Notices March 17, 2023:
General Notices
- Notice of Pre-Application Webinar for RFA-AG-24-004 "Estimating the Monetary Costs
of Dementia in the United States (U01 Clinical Trial Not Allowed)"
(NOT-AG-23-002)
National Institute on Aging
- Notice of Pre-Application Webinar for RFA-AG-24-012 and RFA-AG-24-013 on Postbaccalaureate
and Summer Research Programs in AD/ADRD
(NOT-AG-23-009)
National Institute on Aging
- Notice of Pre-Application Webinar for RFA-DK-22-038, Pilot Interventions to Integrate
Social Care and Medical Care to Improve Health Equity (R01- Clinical Trial Required)
(NOT-DK-23-014)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Changes to RFA-ES-23-007 "Exploratory Grants for Climate Change and Health
Research Center Development (P20 Clinical Trial Optional)"
(NOT-ES-23-009)
National Institute of Environmental Health Sciences
- Notice of Informational Webinar on the NIGMS U-RISE and MARC Programs (T34)
(NOT-GM-23-037)
National Institute of General Medical Sciences
- NHLBI Notice of Clarification and Availability of Frequently Asked Questions (FAQs)
for RFA-HL-23-008 and RFA-HL-23-009 "NHLBI SBIR Phase IIB Small Market Awards"
(NOT-HL-23-082)
National Heart, Lung, and Blood Institute
- Notice of Upcoming Prize Competition Announcement for the TARGETED (Targeted Genome
Editor Delivery) Challenge
(NOT-RM-23-008)
Office of Strategic Coordination (Common Fund)
- Request for Information (RFI): Inviting comments and suggestions on the development
of a EUREKA prize for early prediction of Alzheimer's disease and related dementias
(AD/ADRD)
(NOT-AG-23-012)
National Institute on Aging
- Request for Information (RFI): Inviting input on use of a term like preaddiction for
identifying and intervening in substance misuse and mild/early-stage substance use
disorder
(NOT-DA-23-019)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Notice of Changes to Funding Opportunities
- Notice to Extend the Expiration Date of PAR-20-309 "Alzheimer's Clinical Trials Consortium
(ACTC) Clinical Trials (R01 Clinical Trial Required)
(NOT-AG-23-014)
National Institute on Aging
- Notice to Extend the Expiration Date for PA-20-135, Emergency Competitive Revision
to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
(NOT-OD-23-104)
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured
Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) Mechanism
(U01 Clinical Trial Optional)
(NOT-MH-23-195)
National Institute of Mental Health
- Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured
Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data
Coordinating Center (U24 Clinical Trial Not Allowed)
(NOT-MH-23-196)
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Biotypes of CNS
complications in people living with HIV (P01 Clinical Trial Not Allowed)
(NOT-MH-23-210)
National Institute of Mental Health
National Institute on Drug Abuse
- Notice of Intent to Publish a Funding Opportunity for Emergency Medicine Research
Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent
Clinical Trial Allowed)
(NOT-NS-23-065)
National Institute of Neurological Disorders and Stroke
Requests for Proposal
- Notice of Request for Proposals (RFP), Solicitation 75N91023R00034: NATIONAL CANCER
INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT AWARD
PROGRAM
(NOT-CA-23-050)
National Cancer Institute
Notices of Special Interest
- Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training
following Declared Disasters in 2022 (Admin Supp Clinical Trial Not Allowed)
(NOT-ES-23-007)
National Institute of Environmental Health Sciences
- Notice of Special Interest (NOSI): Availability of Administrative Supplements to IDeA
Awards to Fund Team Science Development Projects
(NOT-GM-23-034)
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Administrative Supplements to Encourage Research
in Valvular Heart Disease (CAROL Act)
(NOT-HL-23-078)
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborative
HIV/AIDS Research Projects at NIMHD-Funded Research Centers in Minority Institutions
(RCMI)
(NOT-MD-23-007)
National Institute on Minority Health and Health Disparities
National Institute of Allergy and Infectious Diseases
Office of Research on Women's Health
Funding Opportunities
- NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under
the Consolidated Appropriations Act, 2023 (Admin Supp Clinical Trial Optional)
(PA-23-134)
National Institutes of Health
Application Receipt Date(s): September 28, 2023
- Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
(PAR-23-122)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of the Director, NIH
Office of Research on Women's Health
Application Receipt Date(s): May 07, 2026
- Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical
Trial Not Allowed)
(PAR-23-123)
National Human Genome Research Institute
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): June 01, 2023
- Biological Testing Facility (X01 Clinical Trial Not Allowed)
(PAR-23-128)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
- Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical
Trial Not Allowed)
(PAR-23-140)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): June 02, 2023
- Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial
Not Allowed)
(RFA-AG-24-004)
National Institute on Aging
Application Receipt Date(s): July 03, 2023
- Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform
(U54 Clinical Trial Optional)
(RFA-AG-24-009)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 31, 2023
- Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment
Protocol (U01 Clinical Trial Not Allowed)
(RFA-AG-24-010)
National Institute on Aging
Application Receipt Date(s): July 02, 2023
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness
(ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)
(RFA-AI-23-019)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 08, 2023
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness
(ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical
Trial Not Allowed)
(RFA-AI-23-020)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 08, 2023
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness
(ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical
Trial Not Allowed)
(RFA-AI-23-021)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 08, 2023
- Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management
and Coordinating Unit (U24 Clinical Trial Not Allowed)
(RFA-CA-23-031)
National Cancer Institute
Application Receipt Date(s): May 05, 2023
- NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical
Trial Not Allowed)
(RFA-EB-23-002)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): May 31, 2023
- Systematic Review of Clinical Outcome Assessments (COAs) for Communication Brain-Computer
Interface Devices (cBCIs) in Amyotrophic Lateral Sclerosis (ALS) (UH2/UH3) Clinical
Trials Not Allowed
(RFA-FD-23-030)
Food and Drug Administration
Application Receipt Date(s): May 24, 2023
- BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation
in the Nervous System (R01 Clinical Trial Not Allowed)
(RFA-NS-24-004)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): January 20, 2026
- BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording
and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
(RFA-NS-24-005)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): January 20, 2026
- NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-23-004)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 08, 2023